Literature DB >> 17879216

Vancomycin-induced nephrotoxicity in rats: is enzyme elevation a consistent finding in tubular injury?

Bijan Naghibi1, Taghi Ghafghazi, Valiollah Hajhashemi, Ardeshir Talebi.   

Abstract

BACKGROUND: Measurement of urinary enzymes facilitates early detection of acute renal impairment. Since in the case of vancomycin-induced nephrotoxicity, there are different findings for the enzyme N-acetyl-beta-D-glucosaminidase (NAG) in various studies, we decided to measure 3 other important urinary enzymes -- gamma-glutamyl-transferase (GGT), alanine aminopeptidase (AAP) and lactate dehydrogenase (LDH) -- in nephrotoxic rats.
METHODS: Male rats were given intraperitoneal injections of vancomycin (VAN) in doses of 50, 100, 200 and 400 mg/kg or normal saline every 12 hours for 7 days. After the 14th injection, the animals were placed in metabolic cages to collect urine samples.
RESULTS: All animals receiving 400 mg/kg VAN died before completion of treatment course. The nephrotoxicity was completely dose-dependent according to pathologic findings. The major insults were in tubules, resembling acute tubular necrosis. GGT, AAP and LDH activity was measured in urine and corrected by dividing it by urinary creatinine (Cr) concentration. LDH activity showed a dose-dependent increase, while GGT and AAP activity decreased in the 200 mg/kg treated group, but only GGT showed a significant difference with controls. Serum urea and Cr and kidney weights were increased and animals' weights were decreased significantly in the 200 mg/kg VAN group compared with other groups.
CONCLUSION: It seems that pathologic assessment remains the most accurate way to diagnose VAN nephrotoxicity. Changes in urinary enzymes could be not detected in minor tubular injuries; however, LDH appears to be the most sensitive factor. In multiple-dose studies, activity of AAP and GGT seems not to be a reliable index of nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879216

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

2.  Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Authors:  Gwendolyn M Pais; Sean N Avedissian; J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Peter C Lamar; Cameron Cluff; Anil Gulati; Julie C Fitzgerald; Kevin J Downes; Athena F Zuppa; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 3.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

4.  Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats.

Authors:  Andrés Quesada; Félix Vargas; Sebastián Montoro-Molina; Francisco O'Valle; María Dolores Rodríguez-Martínez; Antonio Osuna; Isabel Prieto; Manuel Ramírez; Rosemary Wangensteen
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

5.  High-Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin.

Authors:  M D Joshi; J N O'Donnell; N Venkatesan; J Chang; H Nguyen; N J Rhodes; G Pais; R L Chapman; B Griffin; M H Scheetz
Journal:  Clin Transl Sci       Date:  2017-07-04       Impact factor: 4.689

Review 6.  Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers.

Authors:  Félix Vargas; Rosemary Wangesteen; Isabel Rodríguez-Gómez; Joaquín García-Estañ
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.